Market Highlights
Single-Photon Emission
Computed Tomography Market size is expected to reach
at 6.90% CAGR during the forecast period 2023-2032.
The
growing acceptance of Single-Photon Emission Computed Tomography (SPECT)
accustomed by its technical advances is one of the major trends witnessed in
the global SPECT market over the forecast period. Imaging devices are becoming
more advanced, efficient, and evolved in terms of technology. The SPECT scanner
has two integral parts namely computed tomography (CT) and a radioactive
material (tracer). Basically, these tracers are used to diagnose and predict
outcomes in various disease states by monitoring the therapeutic effects.
The Single-Photon Emission Computed Tomography market insights is expected to witness tremendous growth owing to the new 99mtc labelled agents for visualizing biologically significant events, and integration of X-ray tomography (CT) In SPECT. Other key factors such significant investments in R&D and expansions undertaken by key players are contributing towards the growth of the market. However, challenges such as need for skilled professionals, and reimbursement issues, is likely to curb the market growth during the forecast period.
Key
players
The global market is
manifested with the presence of limited companies, leading to the consolidated
nature of the market. The industry rivalry are expected to remain high
throughout the forecast period. Several small and larger companies are involved
in development of Single-Photon Emission Computed Tomography (SPECT) for
diagnostic applications.
The Single-Photon
Emission Computed Tomography Market Players
are GE
Healthcare, Siemens Healthcare, Koninklijke Philips N.V.,
Bruker Corporation, Mediso Ltd., Digirad Corporation, Spectrum Dynamics
Medical, DDD-Diagnostic A/S, MiE America, Inc., CardiArc, Beijing Hamamatsu
Photon Techniques INC., SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
PNPMedM, NuCare Inc., and
others.
Segmentation
The global Single-Photon Emission Computed Tomography market is segmented into type, application, end-users. The Single-Photon Emission Computed Tomography (SPECT) market, by type, the market is segmented into hybrid SPECT systems, and standalone SPECT systems. On the basis of application, the Single-Photon Emission Computed Tomography (SPECT) market is bifurcated into oncology, cardiology, neurology, and others. On the basis of end-user, the market is segmented into hospitals, diagnostic imaging centers, academic & research centers, and others.
Regional
Analysis
The
Americas is the largest in the market owing to the improving research
infrastructure in the region, coupled with the rising awareness among patients
and physicians for radioisotopes. Further, SPECT has reportedly been combined
with CT and MRI to provide detailed anatomical and metabolic information. It is
currently exhibiting a highly lucrative growth rate due to an increased use of
SPECT for diagnosis of cardiac diseases, brain diseases, etc.
The
European region is the second largest SPECT market over the forecast period due
to high acceptance of SPECT in research & development along with the rising
incidence of chronic disease like cancers are also accountable for the growth
of the Single-Photon Emission Computed Tomography (SPECT) market.
The Asia Pacific region is likely to develop at the uppermost CAGR for the Single-Photon Emission Computed Tomography (SPECT) market in the years to come. Moreover, the rising diagnostic care services both at the hospitals and at community level are expected to influence the market in a positive way. The Middle East and Africa accounts for the least market share due to low per capita income and lack of availability of well-trained healthcare professionals.
About
US:
Market Research Future
(MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact
us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th
Floor, New York,
New York 10013
United States of
America
No comments:
Post a Comment